Big Partnerships for Big Data in Healthcare

Big data has made a serious impression in healthcare. A slew of recent announcements have recently come from some of the biggest healthcare organisations, many of them involving collaborations with major players in technology: IBM’s Watson is poised to partner with Apple, Johnson & Johnson, and Medtronic on a number…

THOUGHT PIECE PREVIEW: Alternative Access Pathways: A Bridge to the Future?

Innovation marches on with breakneck speed as oncology products with novel approaches to stopping cancer cruise through regulatory pathways on their way to FDA approval.  However, the gap between FDA approval and EMA approval, as well as the subsequent local reimbursement / pricing assessment can create major disturbances to patient…

Unintended Consequences of NHS Clinical Commissioning Policy Consultations

Since December 2012, NHS England has periodically issued Clinical Commissioning Policies (CCPs), which are coverage determinations for specialised services, including pharmaceuticals, that do not have regulatory approval in England. The stated protocol around CCPs is that when a critical mass of providers (e.g. physicians, nurses, or carers) request funding for…